PARADIGM-HF: MRA and Sacubitril/Valsartan Cut Hyperkalemia Risk PARADIGM-HF: MRA and Sacubitril/Valsartan Cut Hyperkalemia Risk

For those wishing to use a mineralocorticoid-receptor antagonist in HF with a RAAS inhibitor,"it is safer to do so by combining an MRA with sacubitril/valsartan than with an ACE inhibitor."Heartwire from Medscape

Source: Medscape Cardiology Headlines - November 22, 2016 Category: Cardiology Tags: Cardiology News Source Type: news